Safety, Biocompatibility, and Long-Term Sustainability of Nanoparticle-Based Therapeutics: Current Insights and Future Implications
DOI:
https://doi.org/10.29070/dap0bq59Keywords:
Nanoparticles, Biocompatibility, Toxicity, Sustainability, NanomedicineAbstract
Therapeutics derived from nanoparticles provide significant benefits to modern medicine, with the potential to deliver targeted medications, enhance the absorption of drugs by the body, and increase the effectiveness of therapies. The rapid growth of applications for nanomedicine in numerous domains like cancer treatment (oncology), treating heart diseases (cardiovascular), and developing vaccines (vaccine development) necessitates an evaluation of the safety, compatibility, and long-term viability of these products. Therefore, this research focuses on the current state of research in nanoparticle toxicity, their biological effects, and the potential environmental impact of their use through a qualitative and quantitative analysis of peer-reviewed literature (open-access journal articles), scientific articles, and international health publications.
Nano-particle therapy can play an important role in precision medicine; specifically, by providing targeted drug delivery and controlled release of medication into the body. However, the types of toxicological effects caused by the use of nano-particles (i.e. oxidative stress, immune response, accumulation in organs) are not completely understood, nor is there a complete understanding of how biocompatibility is influenced by nano-particle properties (i.e. physico-chemical properties such as size, surface charge, material composition). In addition, the translation of nano-particles into clinical practice faces challenges with regards to reproducibility, scalability and inconsistency in regulatory approval. There are also new environmental concerns associated with nano-particles; specifically, persistence in the environment, Ecotoxicity and sustainability. Green synthesis methods for producing nano-particles as well as lifecycle evaluations of nano-particle applications need to be considered when determining the overall effect of nano-particles on the environment.
Nanoparticle based therapeutics may have a transformative role in medicine but have major unresolved safety issues and sustainability challenges that require caution in future advances. Standardized regulatory frameworks, long-term toxicity studies, and interdisciplinary collaborations and the incorporation of environmental considerations will be important to developing nanomedicine safely and sustainably.
Downloads
References
1. De Jong, W. H., & Borm, P. J. A. (2008). Drug delivery and nanoparticles: Applications and hazards. International Journal of Nanomedicine, 3(2), 133–149. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2673638/
2. Dobrovolskaia, M. A., & McNeil, S. E. (2007). Immunological properties of engineered nanomaterials. Nature Nanotechnology, 2(8), 469–478. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2570468/
3. Jahangirian, H., Lemraski, E. G., Webster, T. J., Rafiee-Moghaddam, R., & Abdollahi, Y. (2017). A review of drug delivery systems based on nanotechnology and green chemistry: Green nanomedicine. International Journal of Nanomedicine, 12, 2957–2978. https://www.dovepress.com/a-review-of-drug-delivery-systems-based-on-nanotechnology-and-green-ch-peer-reviewed-fulltext-article-IJN
4. Jia, Y., Jiang, Y., He, Y., Zhang, W., Zou, J., Magar, K. T., Boucetta, H., Teng, C., & He, W. (2023). Approved nanomedicine against diseases. Pharmaceutics, 15(3), 774. https://www.mdpi.com/1999-4923/15/3/774
5. Khan, I., Saeed, K., & Khan, I. (2019). Nanoparticles: Properties, applications and toxicities. Arabian Journal of Chemistry, 12(7), 908–931. https://www.sciencedirect.com/science/article/pii/S1878535217300990
6. Khan, I., Saeed, K., & Khan, I. (2019). Nanoparticles: Properties, applications and toxicities. Arabian Journal of Chemistry, 12(7), 908–931. https://www.sciencedirect.com/science/article/pii/S1878535217300990
7. Longmire, M., Choyke, P. L., & Kobayashi, H. (2008). Clearance properties of nano-sized particles and molecules as imaging agents: Considerations and caveats. Nanomedicine, 3(5), 703–717. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2775654/
8. Monopoli, M. P., Åberg, C., Salvati, A., & Dawson, K. A. (2012). Biomolecular coronas provide the biological identity of nanosized materials. Nature Nanotechnology, 7(12), 779–786. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534012/
9. Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. del P., Acosta-Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., Habtemariam, S., & Shin, H.-S. (2018). Nano based drug delivery systems: Recent developments and future prospects. Journal of Nanobiotechnology, 16(1), 71. https://link.springer.com/article/10.1186/s12951-018-0392-8
10. Sim, S., & Wong, N. K. (2021). Nanotechnology and its use in imaging and drug delivery (Review). Biomedical Reports, 14(5), 42. https://pmc.ncbi.nlm.nih.gov/articles/PMC7953199/
11. Thapa, R. K., & Kim, J. O. (2023). Nanomedicine-based commercial formulations: Current developments and future prospects. Journal of Pharmaceutical Investigation, 53(1), 19–33. https://pmc.ncbi.nlm.nih.gov/articles/PMC9761651/
